This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Xinkang Wang: Innovator in Protein Kinase Inhibition
Introduction
Xinkang Wang is a notable inventor based in Berwyn, PA (US). He has made significant contributions to the field of biochemistry, particularly in the area of stress-activated protein kinases.
Latest Patents
Wang holds a patent for a method aimed at inhibiting stress-activated protein kinases (SAPKs). This invention involves administering an effective amount of a compound that acts as a dual non-selective β-adrenoceptor and α-adrenoceptor antagonist. His innovative approach has the potential to impact therapeutic strategies for various stress-related conditions.
Career Highlights
Xinkang Wang is associated with SmithKline Beecham Corporation, where he has been instrumental in advancing research and development in pharmacology. His work has contributed to the understanding of protein kinases and their role in cellular stress responses.
Collaborations
Wang collaborates with Tian-Li Yue, enhancing the research efforts within their team. Their combined expertise fosters innovation and drives forward the development of new therapeutic methods.
Conclusion
Xinkang Wang's contributions to the field of protein kinase inhibition exemplify the impact of innovative research in biochemistry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile